88 related articles for article (PubMed ID: 9650403)
1. [Reduced serum dehydroepiandrosterone levels in postmenopausal osteoporosis].
Fingerová H; Matlochová J
Ceska Gynekol; 1998 Apr; 63(2):110-3. PubMed ID: 9650403
[TBL] [Abstract][Full Text] [Related]
2. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
[TBL] [Abstract][Full Text] [Related]
3. Dehydroepiandrosterone sulphate in the diagnosis of osteoporosis.
Miklós S
Acta Biomed Ateneo Parmense; 1995; 66(3-4):139-46. PubMed ID: 8578930
[TBL] [Abstract][Full Text] [Related]
4. Sex-specific association of serum dehydroepiandrosterone and its sulfate levels with osteoporosis in type 2 diabetes.
Li S; Li W; Chang L; Wan J; Chen S; Zhang X; He Q; Liu M
J Bone Miner Metab; 2024 May; 42(3):361-371. PubMed ID: 38769209
[TBL] [Abstract][Full Text] [Related]
5. [Number of teeth and hormonal profile of postmenopausal women with osteoporosis, osteopenia and normal bone mineral density--a preliminary study].
Stagraczyński M; Kulczyk T; Leszczyński P; Męczekalski B
Pol Merkur Lekarski; 2015 Oct; 39(232):214-8. PubMed ID: 26608487
[TBL] [Abstract][Full Text] [Related]
6. Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.
Földes J; Lakatos P; Zsadányi J; Horváth C
Eur J Endocrinol; 1997 Mar; 136(3):277-81. PubMed ID: 9100552
[TBL] [Abstract][Full Text] [Related]
7. The evaluation of hormonal and psychological parameters that affect bone mineral density in postmenopausal women.
Seven A; Yuksel B; Kabil Kucur S; Yavuz G; Polat M; Unlu BS; Keskin N
Eur Rev Med Pharmacol Sci; 2016; 20(1):20-5. PubMed ID: 26813449
[TBL] [Abstract][Full Text] [Related]
8. Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women.
Haden ST; Glowacki J; Hurwitz S; Rosen C; LeBoff MS
Calcif Tissue Int; 2000 Jun; 66(6):414-8. PubMed ID: 10821876
[TBL] [Abstract][Full Text] [Related]
9. CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women.
Bácsi K; Kósa JP; Borgulya G; Balla B; Lazáry A; Nagy Z; Horváth C; Speer G; Lakatos P
Calcif Tissue Int; 2007 Mar; 80(3):154-9. PubMed ID: 17334880
[TBL] [Abstract][Full Text] [Related]
10. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
11. The association of serum osteoprotegerin and osteoporosis in postmenopausal hemodialysis patients: a pilot study.
Wu WT; Lee RP; Wang CH; Fang TC; Lin NT; Chen IH; Hsu BG
J Womens Health (Larchmt); 2010 Apr; 19(4):785-90. PubMed ID: 20210559
[TBL] [Abstract][Full Text] [Related]
12. [Impact of CYP3A7*1C polymorphism on bone mineral content in postmenopausal women].
Bácsi K; Kósa J; Lazáry A; Balla B; Horváth H; Takács I; Nagy Z; Speer G; Lakatos P
Orv Hetil; 2007 Jul; 148(27):1273-80. PubMed ID: 17604264
[TBL] [Abstract][Full Text] [Related]
13. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
14. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study.
Laughlin GA; Barrett-Connor E
J Clin Endocrinol Metab; 2000 Oct; 85(10):3561-8. PubMed ID: 11061502
[TBL] [Abstract][Full Text] [Related]
15. Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women.
Bonadonna S; Mazziotti G; Nuzzo M; Bianchi A; Fusco A; De Marinis L; Giustina A
J Bone Miner Res; 2005 Oct; 20(10):1837-44. PubMed ID: 16160741
[TBL] [Abstract][Full Text] [Related]
16. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
Dorgan JF; Stanczyk FZ; Longcope C; Stephenson HE; Chang L; Miller R; Franz C; Falk RT; Kahle L
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
[TBL] [Abstract][Full Text] [Related]
17. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
Saruç M; Yüceyar H; Ayhan S; Türkel N; Tuzcuoglu I; Can M
Hepatogastroenterology; 2003; 50(51):771-4. PubMed ID: 12828082
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density, calcaneal ultrasound, and bone turnover markers in women with ankylosing spondylitis.
Speden DJ; Calin AI; Ring FJ; Bhalla AK
J Rheumatol; 2002 Mar; 29(3):516-21. PubMed ID: 11908565
[TBL] [Abstract][Full Text] [Related]
19. Effect of DHEA supplementation on serum IGF-1, osteocalcin, and bone mineral density in postmenopausal, glucocorticoid-treated women.
Papierska L; Rabijewski M; Kasperlik-Załuska A; Zgliczyński W
Adv Med Sci; 2012 Jun; 57(1):51-7. PubMed ID: 22430044
[TBL] [Abstract][Full Text] [Related]
20. Screening for osteoporosis using easily obtainable biometrical data: diagnostic accuracy of measured, self-reported and recalled BMI, and related costs of bone mineral density measurements.
van der Voort DJ; Brandon S; Dinant GJ; van Wersch JW
Osteoporos Int; 2000; 11(3):233-9. PubMed ID: 10824239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]